Pulmonology Flashcards

1
Q

Congenital Lung Malformations

A

Pulmonary hypoplasia- a lung that does not develop properly

Sequestration- born w/ adherent lung tissue that doesn’t function like normal lung tissue

Congenital cystic adenomatoid malformation (CCAM)- cysts develop in lobes of the lung, considered benign but can develop into cancer when they are older

Congenital lobar emphysema- hyperinflation of the lobe, deficient development of bronchial cartilage leading to over inflation, surgical intervention once child is older

Lung agenesis- lung didn’t develop properly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pneumonia pathophysiology

A

Infectious pathogen invades lung tissues → activation of body’s defense mechanisms
- cytokines
- polymorphonuclear neutrophils (PMNs)
- macrophages
→ Edema and increased permeability allowing fluid into alveoli and surrounding tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pneumonia types

A

Bronchopneumonia- infection of bronchioles and alveoli

Lobar pneumonia- most common, consolidation

Interstitial pneumonia- walls of alveoli & bronchi infected, occurs most often in viral cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pneumonia etiology

A

Viral- influenza, RSV, adenovirus
(lung defenses are deceased d/t increases secretions → disrupts normal flora and normal phagycytosis → lungs are more susceptible)

Bacterial- strep pneumoniae, mycoplasma, chlamydia, TB

Fungal

Age Variants

**Neonatal **
-viral: CMV
-bacterial: group b strep, gram negative enteric, Listeria, chlamydia

Infants
-viral (most common): RSV, parainfluenza, adenovirus, metapneumovirus
-bacterial: s. pnemoniae, haemophilus influenzae, mycoplasma pneumoniae, mycobacterium tuberculosis, bordetella pertussis

preschool
-viral (most common): RSV, parainfluenza, influenza, adenovirus, metapneumovirus
-bacterial: s. pnemoniae, h. influenzae, m. pneumoniae, m. tuberculosis, chlamydia

school age
-viral: RSV, parainfluenza, influenza, adenovirus, metapneumovirus
-bacterial: M. pneumoniae, C. pneumoniae, S. pneumonia, M. tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pneumonia HPI/PE

A

HPI:
recent illness
cough
chest discomfort
fever
did they recently have virus and now have cough + fever?

s/s:
Cough, fever, poor feeding, retractions, nasal flaring, tachypnea, hypoxemia
ill appearing
pleural rub may not be appreciated in infants, but can be heard in older child (also rales, crackles)

PE:
Crackles, diminshed breath sounds, bronchial sounds, egophany
Wheezing associated w/ viral etiology
Dullness to percussion, pain, w/pleural friction rub think pleural effusion

Imaging not routinely recommended if stable. Consider if hospitlization, confirm diagnosis when other potential etiology cannot be determined; complicated/severe cases or recurrent PNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PNA differntials/treatment

A

Differentials:
FB
Asthma
Bronchiolitis
Heart failure
Sepsis

Treatment
(think about common etiology)
Amoxicillin 90mg/kg/day or Augmentin
PCN allergy: Cefdinir 14 mg/kg/day or clindamycin 30-40 mg/kg/day divided into 3-4x/day (5-7 days)
Azithromycin 10mg/kg/day x1, then 5 mg/kg/day for 4 more days

Pearls:
- in infants < 6 mts, consider c. trachomatis, treat w/ azithtomycin 20 mg/kg/day x 3 days
- consider other etiology if not responding to initial treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bronchiolitis

A

Inflammation & swelling of bronchioles (smaller airways)

Lower respiratory tract infection <2 yrs old

s/s: Acute wheezing, tachypnea, WOB, cough, rhinorrhea, congestion

Viral etiology: RSV, parainfluenza, human metapneumovirus

PE:
General appearance is irritable infant/ toddler, fever
HEENT: rhinorrhea, cough, nasal flaring
Lungs: tachypnea, crackles, wheezing, grunting, hyperresonance on percussion
Heart: tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bronchiolitis pathophysiology/clinical course

A

Typically a prodrome of mild illness → increased respiratory symptoms,peak around days 5-7, lasting up to 21 days

Pathophysiology:
virus infects epithelial cells in URT → sloughed to LRT → further edema, sloughing into airway, mucus → obstruction + air trapping

(day 0-6)
Upper respiratory: virus infects epithelial cells that are sloughed to lower respiratory tract. Lower respiratory is normal
(day 6-18)
Lower Respiratory: further epithelial infection w/ edema, sloughing of cells into airway, mucous production and edema associated with obstruction & air trapping
Ciliary function impaired
Polymorphonuclear cells and lymphocytes proliferate in an inflammatory response
(day 18-22)
Upper & lower respiratory: regeneration of epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bronchiolitis Diagnosis

A

Baby or child with coryzal prodrome lasting 1-3 days followed by:
- persistant cough and
- tachypnea or retractions and
- wheezes or crackles on ausculatation

fever and poor feeding are common findings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bronchiolitis treatment

A

Mild-moderate w/ adequate oxygen saturation (90%)
Supportive care: Hydration, saline and nasal suctioning, monitoring closely

Anticipatory guidance regarding disease process- let parents know things may get worse before they get better

When to f/u or seek emergent care- not feeding well, vomiting, > 6 hrs w/o wet diaper
Increasing distress or severe disease process
ED evaluation, oxygen support, support for hydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bronchiolitis differentials

A

PNA
Pertussis
Recurrent wheezing
Chronic pulmonary disease
FB
Congenital heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

RSV s/s

A

spread by respiratory droplets

gradual onset, may have 3-7 days of prodromal symptoms

s/s: fever, profuse rhinorrhea, cough, wheezing, respiratory distress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

RSV treatment

A

Supportive care:
Nasal suctioning (carefully, PRN), saline, humidified air
Monitor closely for respiratory compromise

Hospitalization if:
Desaturation despite airway suctioning
Poor feeding
Vomiting

Treatment:
oxygen if needed
suctioning
treat secondary infection (pna. aom)
IV fluids if needed
PICU for progressing respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

RSV Prophylaxis

A

Nirsevimab (one dose)
Infants 0-8mts born during or entering first RSV season
8-19 mts who are at increased risk for severe RSV disease and entering their second RSV season

Palivizumab (synergis) (monoclonal antibiody)
Born </= 35 weeks gestation and <6 mts old at beginning of RSV season

<24 mts in 2nd RSV season with high-risk conditions (BPD, CHD) - given once a month during RSV season

(High risk= premature birth, <29 week gestation, chronic lung disease of prematurity, hemodynamically significant congenital heart disease, severe immunocompromise, severe cystic fibrosis)

Adult vaccines
Arexvy (nirsevimab) - 60 yrs + (late summer- early fall, before RSV starts to spread)
Abrysvo- maternal vaccine administered 32-36 weeks gestation, september-january

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bronchitis

A

Nonspecific Inflammation & swelling of bronchi (larger airway) secondary to viral infection (inflammatory response to prior infection)

Pathophysiology:
Epithelium of bronchi affected → inflammatory cells & cytokines released → inflammation of epithelium w/ mucus production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bronchitis HPI/PE

A

HPI:
May report viral symptoms - rhinorrhea, nasal congestion, fever, sore throat
Cough develops, dry hacky then productive
Chest pain in older children

PE:
Afebrile or low-grade temp
Rhinitis, nasopharyngitis, conjunctivitis, may see petechiae around periorbital region from cough
Lungs
-Early- normal exam
-Late phase- may hear coarse sounds, crackles or wheezing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Bronchitis differentials/treatment

A

Differentials:
Pertussis
Asthma
Bronchiolitis
Wheezing
Pneumonia

Treatment:
Supportive- lots of fluid, rest, lay on extra pillow
Caution w/ OTC cough suppressants in ages 4-11, contraindicated < 4 y/o
Antibiotics not necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pertussis

A

“whooping cough”
caused most often by Bordatella Pertussis- gram negative coccobacillus
spread via respiratory droplets
incubation period 7-10 days

classic presentation: paroxysms of coughing, inspiratory whoop and post tussive vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pertussis Phases

A

Catarrhal phase:
- mild, nonspecific symptoms- clear rhinorrhea, cough, congesstion, afebrile or low grafr

Paroxymal phase:
- intermittent dry, hacking cough (prolonged and can see gagging, cyanosis or classic whoop in older chidlren
- post-tussive emesis in <12 mts old
- in babies may see apnea spells or color changes d/t intensity of coughing

Convalescent stage:
- decreased cough severity and frequency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pertussis PE

A

HEENT- petechial hemorrhage (from intensity of coughing), in catarrhal phase- rhinorrhea, nasal congestion
Skin- petechial rash

Infant exceptions:
May lack cararrhal phase
Gaggings, gasping, eye bulging w/ coughing in < 6 mts
Apnea, respiratory distress, seizures, shock, poor weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pertussis diagnostics

A

CBC if febrile- unimmunized may have leukocytosis

Chest radiograph- normal in most cases, may see pneumomediastinum, pneumothorax, perihilar infiltrates

Pertussis specific (ideal to conduct early, within 3 weeks of symptoms)
- Culture- highest specificity, low sensitivity (ability to identify absence of dx, true negative)
- PCR- more sensitive test (ability to identify presence of dx, true positive)
- Serum- variable sensitivity/specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pertussis differentials

A

URI, adenovirus
RSV
Pneumonia
Other bordetella infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pertussis Treatment

A

Guidelines:
If clinical picture leads you to suspect Pertussis- treat if < 21 days of symptoms onset
If culture is positive- treat
Infants treat within 6 weeks of onset
Older children and adolescents treat within 3 weeks of symptom onset

Treatment= macrolide abx
< 1 month: Azithromycin 10 mg/kg/day
**1-5 mts: **
Azithromycin 10 mg/kg/day
Erythromycin 40 mg/kg/day QID x 14 days
Clarithromycin 15 mg/kg/day BID x 7 days
TMP-SMX if allergic to macrolides (>2mts)
6mts+:
Azithromycin 10 mg/kg/day x1 day, 5 mg/kg/day x 4 days
Erythromycin 40 mg/kg/day QID x 7-14 days (maximum 2 g/day)
Clarithromycin 15 mg/kg/day BID x 7 days (max 1 g/day)

household contacts should receive macrolide abx as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Influenza

A

Viral infection
Antigenic types include A, B & C
Type A has surface proteins which allow for further subtyping- Hemagglutinin (H) & Neuraminidase (N)

Children shed virus for about 10 days
Easily spread
Incubation 1-4 days, contagious 24 hrs prior to symptom onset

High risk of hospitalization:
< 2 y/o and adults >65 yrs
Underlying immune compromising disease
Risk of death
unimmunized children
<5 yrs w/ high risk conditions

25
Influenza HPI/PE
HPI: Sudden onset of high fever (102-106F) Headache, chills, cough, sore throat, body ache Coryza (inflammation of nasal mucous membrane) Severe - may see chest pain, croup like symptoms, lung infiltrates and children may be ill appearing PE: Ill appearing, weakness Rhinorrhea Conjunctival injections Clear TMs Pharyngeal injection Respiratory- clear or atelectasis (if they are starting to develop inflammation to lower respiratory tract) Cardiac- tachycardia if febrile; concern of myocarditis if complaint of chest pain Abdominal exam benign in most cases (flu B may have some GI symptoms)
26
Influenza differentials/diagnostics
Differentials: Other viral URI (covid, parainfluenza, rhinovirus) Croup Pneumonia Epiglottitis Diagnostics: Rapid antigen testing (if family member has flu and child is brought in w/ symptoms but rapid is negative, can clinically diagnosis) PCR viral panels Viral culture (within 72 hrs of symptoms onset) CBC- leukopenia
27
Influenza Treatment
Supportive: Fluid, rest, OTC fever reducer (APAP, ibuprofen) No ASA containing products- risk of Reye syndrome- encephalopathy from reaction b/w ASA and influenza virus Isolation / social distancing Good handwashing Antiviral (Tx and post exposure prophylaxis) - should be taken within 48 hrs of symptoms starting -Oseltamivir -Zanamivir -avoid in asthmatics - risk of bronchospasm
28
COVID 19
Viral infection caused by SARS COV-2 **HPI**: Loss of taste or smell Fever, myalgia, headache Cough, sore throat GI: nausea, vomiting, diarrhea (50% of children can be asymptomatic) **PE:** Mild or ill appearing Congestion, rhinorrhea, erythematous posterior oropharynx Ears- usually not involved, pearly TMs Respiratory - WNL besides cough, usually no wheezing unless child has underlying asthma or pulmonary disease Cardio- WNL, unless signs of myocarditis (chest pain, tachycardia) Differntial: other URI (influenza, parainfluenza, human metapneumovirus, RSV) Treatment: Supportive care Antiviral -12-18 yr emergency use authorization: Nirmatrelvir and Ritonavir w/i 5 days of symtpom onset and positive covid 19 test side effects: diarrhea, nausea, vomiting, loss of taste or smell, metallic taste in mouth, blood pressure changes, myalgia risk for drug drug interaction
29
Multisystem Inflammatory Syndrome of childhood (MIS-C)
2-6 weeks post covid infection 1-2% mortality rate Consider in child who has had recent covid, and starts developing new fever Confirm w/ PCR testing when possible s/s: - Fever >100.4 - Elevated CRP (> 3.0) Organ involvement - Cardiac, mucocutaneous, GI or hematologic - Redness of eyes, chest pain, beefy red mucous membranes, stomach ache
30
Brief Resolved Unexplained Event (BRUE)
Defined as brief, **resolved** unexplainable event including 1 or more of the following: Cyanosis or pallor Change in respiration- apnea (cessation of breathing), decreased RR or irregular rate Change in muscle tone Change in responsiveness (diagnosis of exlclusion) risk factors contributing to alternative diagnoses or further eval: GER Neurologic problems Some respiratory infections Toxic ingestion Child abuse Cardiac disease Upper airway obstruction
31
BRUE management
Full PE including vitals Observation for 1-4 hrs (typically done in higher acuity setting but can be observed in clinic setting as well) Educate parents about BRUE- often time it is one time occurrence, but if it repetitive, then bigger workup will be necessary d/c home if stable; close followup within 24 hrs If parents are uncomfortable or cannot provide care- consider observation in hospital setting Consider EKG Pertussis test- infants <6mts can have apneic episodes from coughing
32
Spirometry
5 yrs and up Best of 3 attempts in asthma: establish diagnosis, follow progression of dx, establish need to step up or down on maintenance meds Intepretation: Prebronchodilator and post bronchodilator measurement Lung function measured before and after albuterol administration To diagnose asthma, there should be increase in lung function after albuterol administration - at least a **12% difference** should be seen to diagnose % predicted - values are based on sex, height, age
33
FVC (forced vital capacity)
total volume of air that can be exhaled during a maximal forced exhalation effort
34
FEV1 (forced expiratory volume in 1 second)
the volume of air exhaled in the first second under force after a maximal inhalation
35
FEV1/FVC ratio
the percentage of the FVC that is expired in 1 second
36
FEF 25-75% (forced expiratory flow over the middle one half of the FVC)
average flow after 25% of the FVC has been exhaled to the point at which 75% of the FVC has been exhaled
37
Cystic Fibrosis
Autosomal recessive CF transmembrane conductance regulator (CFTR) defect - involved in the transport of **sodium** and **chloride** ions across the apical membrane of epithelial cells - abnormal CFTR protein **traps** choride and water **inside** the cell → **mucus** outside **thicker** and stickier Lung transplant extends life, but is not a cure
38
CF diagnosis
sweat chloride test >60 mmol/L x2 **0-6mts** 0-29 CF unlikely 30-59 intermediate >/= 60 indicative of CF >6mts, children, adults 0-39 CF unlikely 40-59 intermediate >/= 60 indicative of CF
39
CF clinical presentation
- recurrent sinus or pulmonary infections - steatorrhea - growth failure - meconium plug (15-20% of infants w/ CF) - meconium ileus & bowel obstruction - rectal prolapse Less common: prolonged neonatal jaundice, hypoproteinemia enteropathy, hemorrhaic disease of the newborn Older children: - nasal polyps - bronchiectasis - digital clubbing - growth failure - distal intestinal obstruction syndrome - liver disease - pancreatitis
40
CF airway clearance strategies
CPT Devices Huff cough- begin teaching as toddler, helps more effectively mobilize mucus from deeper in lungs Aerobic exercise Postural drainage- < 2yrs old, rotate child to promote drainage through gravity
41
CF nutritional defecits
- malabsorption of fats and proteins - fat soluble vitamin (ADEK) deficiency - malnutrition and FTT - 120-125% of RDA of calories - 80-85% are pancreatic insufficient Pancreatic Enzyme Replacement Therapy - indicated in 85% of CF pts - Creon most commonly used - Usual dose 2000-2500 units/kg of lipase per meal (max 10K units/day) - If enteral (tube) nutrition needed, special cartridges automatically add the enzymes based on the volume (Relizorb)
42
CF Pulmonary Exacerbation
s/s: - increased cough, sputum - new crackles - new radiographic findings - weight loss, decreased appetite - decreased PFT and O2 sat - decreased exercise tolerance, fatigue - often triggered by viral infection management: - abx therapy improve pulmonary function, exercise tolerance and quality of life - may include anti inflammatory meds (azitrhomycin- has anti inflammatory properties, or ibuprofen) - mild exacerbation- oral and or inhaled abx based on culture sensitivity **- P. aeruginosa, S. aureus common **- 14 day or longer course until clinical improvement is achieved - send sputum sample when able
43
CF complications
**Pulmonary** asthma hemoptysis pneumothorax chronic sinusitis **GI/Hepatobiliary** distal intestinal obstruction syndrome (DIOS) gall stones CF liver disease GERD **Endrocrine** CF related diabetes - annual screening oral glucose tolerance test starting at 10 yrs **Mental Health** Anxiety/depression **Other** Arthritis Osteopenia/porosis
44
45
Tuberculosis
caused by Mycobacterium tuberculosis complex air borne tradmission, not spread by contact
46
TB Infection
previously called latent TB infection Criteria- infection in person who: -has no symptoms or signs of disease and - has normal chest x ray findings and - has positive test result indicating infection
47
TB disease
person with infection in whom symptoms, signs, and radiographic manifestations are apparent, dx can be pulmonary or extrapulmonary s/s (appear 1 month- 2 yrs after infection) - fever - weight loss or poor weight gain - cough - night sweats - chills - radiological findings vary
48
TB testing
**Tuberculin skin testing**- tuberculin units injected intradermally creating a palpable wheal 6-10mm in diameter - preferred method for < 2 yrs old - interpret 48-72 hrs after injection - BCG (Tb vaccine overseas) can produce false positive **Interferon gamma release assay (IGRA)**- measure ex vivo interferon gamma production from T lymphocytes in response to stimulation w/ antigens specific to M. Tuberculosis complex performs reliably in children >2 yrs, very unreliable <3 mts positive test indicates infection, not disease If positive- ask about sx of dx, exposure to tb pts, perform PE for signs of dx, obtain CXR If CXR positive- obtain sputum or gastric aspitate sampling <12 mts consider lumbar puncture if any neuro s/s- higher risk for neurological impact from dx
49
Tuberculin skin testing interpretation
**Induration >/= 5 mm** - considered positive in: - Children in close contact w/ known or suspected contagious people w/ TB disease - Children suspected to have TB disease: - Findings on chest radiograph consistent w/ active or previous TB disease - Clinical evidence of TB disease - Children receiving immunosuppressive therapy or w/ immunosuppressive conditions, including HIV **Induration >/= 10 mm** Children with increased risk for disseminated TB disease: - Children younger than 4 yrs - Children with other medical conditions, including Hodgkin disease, lymphoma, diabetes mellitus, chronic renal failure, or malnutrition - Children born in high prevalence regions of the world - Children with significant travel to high prevalence regions of the world - Children frequently exposed to adults who are living with HIV, experiencing homelessness, or incarcerated or to people who inject or use drugs or have alcohol use disorder **Induration >/= 15 mm** Children w/o any risk factors
50
TB Infection treatment
Regimens: 12-week course of once-weekly dosing of isoniazid and rifapentine (treatment for those 2 years and older) 4-month course of rifampin daily (preferred regimen when isoniazid resistance is likely) 3 months of daily isoniazid and rifampin (no age restriction) 9-month course of isoniazid monotherapy daily (most widely recommended and used treatment for pediatric tuberculosis infection)
51
TB Disease treatment/management
**Direct observation therapy**- intervention by which medications are taken by patient while a healthcare professional or trained third party observes and documents ingestion of each dose and assesses for adverse drug effects **6 mts, 4 drug regimen** Rifampin, Isoniazid, Pyrazinamide, and Ethambutol (RIPE) for the first **2 mts** (daily for at least 5 days/wk) Isoniazid and Rifampin for the remaining **4 mts** (3 times/wk) Other regimens recommended when drug resistance is likely Evaluation/Monitoring: CXR after 2 mts of therapy DOT to monitor for adherence and side effects Regular check ins with ID team to assess adherence and side effects Possible side effects can include** severe hepatitis** -should call for signs of **hepatotoxicity** - N/V, abdominal pain, jaundice
52
Laryngomalacia
caused by collapse on inspiration of the soft, immature cartilages of the larynx structural weakness of tissues of the larynx (especially in supraglottic area) → tissue collapses inward during inspiration → obstruction Clinical Manifestations: - noisy breathing that worsens w/ feeds or when supine (positional) - on exam may note stridor when feeding or w/ excitement Varying degrees of severity -mild - just noisy breathing w/o airway compromise or growth issues -as severity increases, increased likelihood of airway compromise and FTT d/t increased caloric demands
53
Laryngomalacia differential diagnoses
**Unilateral or bilateral vocal cord paralysis** - 1 or both vocal cords do not open or close properly - can be congenital or associated w/ medical conditions or surgeries - *usually presents w/ inspiratory and expiratory stridor* **Laryngeal papillomatosis** - Associated w/ HPV infection that has settled in airways - Can be d/t maternal infection in infants - Small tumors form inside of larynx **Subglottic hemangioma** - Form a mass below vocal cords - Grow rapidly for 12-18 mts then atrophy **Subglottic stenosis** - Congenital or acquired (prolonged intubation) narrowing of the airway in the subglottic region *- Stridor is not positional* **Tracheomalacia** - Structural abnormality of the tracheal cartilage inducing collapsibility of the trachea - Kids can be severely affected and require trach - Can co-occur w/ laryngomalacia - *Expiratory sounds are usually present* **Vascular ring** - Aortic arch or its branches form a ring around the trachea or esophagus or both
54
Laryngomalacia H&P
**History** Birth history: procedures, intubations, NICU Breathing history at home Feeding habits Sleeping habits Medical history: GERD, recurrent PNA. FTT **Physical Exam** Oral cavity Clefts Micrognathia (mandibular hypoplasia), glossoptosis (downward displacement of tongue), upper airway obstruction associated with Pierre Robin Syndrome Nose - patency and choanal atresia (partial or full occlusion of nasal passage) Neck - retractions and masses or vascular lesions Chest- auscultation and inspection for retractions Beardlike distribution of hemangiomas associated w/ airway hemangioma
55
Laryngomalacia diagnostics/treatment
Flexible laryngoscopy - is mainstay for diagnostic evaluation of the infant with stridor - *Gold standard* for diagnosing laryngomalacia- not always done Modified barium swallow with speech therapist - Assess for feeding problems - Live fluoro study with mixed contrast and have baby drink it- evaluate how it goes down from esophagus into stomach and move into bowels - Speech therapist will watch for signs of reflux or contrast going down wrong tube Polysomnogram - Is child is having sleep concerns - Assess for apneic episodes Treatment: Refer to pediatric pulmonology Mild to moderate stridor without feeding difficulties → observation: - Continue to monitor weight gain and development of severe symptoms - Feed upright - Antireflux medications if indicated If feeding difficulties are present- thickening feeds Surgical intervention for those severely affected (10-20%) Resolution occurs in majority of patients by 12-18 mts
56
X-Ray Terminology
Radiolucent- allows crays to pass through, appears dark on film (air) Radiopaque- impenetrable to x-rays, appears light on film (bone) Density- composition of structures - Air-black, not dense - Fluid/soft tissues- gray, variable density - bones - white, dense - lead- pure white, most radiopaque
57
Evaluating lung fields on xray
**Pneumothorax** - pulmonary markings replaced by *dark edge* (air leaked into pleural space), trachea may deviate away from PTX **Pneumomediastinum**- mediastinum *encircled by a dark line* (ring of air around mediastinum) **Atelectasis **(collapsed alveoli)- density of lung appears *more opaque* (white-collapsed alveoli → *lost air *→ less dense, so will appear grey or white), may be difficult to differentiate heart border **Infiltrates**- increased *haziness* d/t loss of air from alveoli being *consolidated* with pulmonary edema, pna, purulent fluids (Causes: dema, hemorrhage, pulmonary venous congestion, infectious pneumonia, aspiration)
58
CXR Systematic Approach
Check for right patient, date and time Step 1: Tube placements - ETT- usually 2nd-3rd rib, at least 1 cm above carina - NG- well into stomach, below diaphragm - ND (nasoduodenal)- into stomach, curved and back right, past the spine (in stomach, through pylorus and curved back across into small intestine) Step 2: Evaluate lung fields - changes may be symmetric and diffuse, or lobar Step 3: Evaluate cardiac structures - Cardiac silhouette - **Normal size is no more than ½ of the chest width** - Central line placement in RA, IVC or SVC (not RV) - PA catheter- catheter extends down through RA, RV and up into PA Step 4: Evaluate bone structures Step 5: Evaluate abdomen